Clinical trial MONALEESA-7
A Phase III randomized, double-blind, placebo-controlled study of LEE011 or placebo in combination with tamoxifen and goserelin or a non-steroidal aromatase inhibitor (NSAI) and goserelin for the treatment of premenopausal women with hormone receptor positive, HER2-negative, advanced breast cancer
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | Novartis |
| EudraCT Identifier | 2014-001931-36 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02278120 |
| Inclusion criteria | ER+/HER2-. Metastatic. Pre-menopausal |
| Last update |